Hepatocellular Carcinoma Cells Induce Regulatory T Cells and Lead to Poor Prognosis via Production of Transforming Growth Factor-β1

Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology
Yi WangXizhong Shen

Abstract

Regulatory T cells (Tregs) are associated with a poor prognosis in hepatocellular carcinoma (HCC). The purpose of the study was to explore the mechanisms of Tregs accumulation in HCC. We analyzed the frequency of Tregs in HCC by flow cytometry and immunohistochemistry. We also established a transforming growth factor (TGF)-β1-knockdown cell line by lentivirus-mediated RNA interference. Mouse CD4+CD25- T cells were cultured in supernatants from various cell lines. HCC patients had a high frequency of Tregs, and high numbers of Tregs correlated with a poor prognosis. Liver cancer cells induced Treg production by secreting TGF-β1. In vivo experiments indicated that knockdown of TGF-β1 reduced the numbers of Tregs and metastatic nodules in mice. These results indicate that cancer-secreted TGF-β1 may increase Tregs, and TGF-β1 knockdown might impair immunosuppression in the tumor microenvironment by decrease Tregs.

Citations

Jan 23, 2017·Critical Reviews in Oncology/hematology·Cinzia SolinasMario Scartozzi
Jan 31, 2018·Nature Immunology·Marc RingelhanMathias Heikenwalder
Jan 6, 2018·Expert Opinion on Drug Delivery·Chintan BhavsarAbdelwahab Omri
Oct 21, 2017·Cancer Immunology, Immunotherapy : CII·Joseph M ObeidOsama E Rahma
Nov 9, 2017·Molecular Medicine Reports·Shuang LiuJun Zeng
Apr 12, 2019·International Journal of Molecular Sciences·Antonio SircanaGiovanni Musso
Feb 26, 2020·Bioscience Reports·Bin LiangTianjiao Wang
Jul 4, 2020·Journal of Gastrointestinal Cancer·Ramazan DertliHuseyin Ataseven
May 16, 2020·Cancer Research·Aaron H MorrisLonnie D Shea
Jan 12, 2021·Molecular Therapy : the Journal of the American Society of Gene Therapy·Mai Abdel Mouti, Siim Pauklin
Jan 1, 2021·International Journal of Radiation Oncology, Biology, Physics·Jin Hee ParkSaeGwang Park
Apr 4, 2021·Cancers·Zongtai QiSidharth V Puram
Jan 7, 2018·Biochimica Et Biophysica Acta. Molecular and Cell Biology of Lipids·Mingjing ShenSoo Ok Lee

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.